Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of the Digene HC2 assay and the Roche AMPLICOR human papillomavirus (HPV) test for detection of high-risk HPV genotypes in cervical samples.
Sandri MT, Lentati P, Benini E, Dell'Orto P, Zorzino L, Carozzi FM, Maisonneuve P, Passerini R, Salvatici M, Casadio C, Boveri S, Sideri M. Sandri MT, et al. Among authors: zorzino l. J Clin Microbiol. 2006 Jun;44(6):2141-6. doi: 10.1128/JCM.00049-06. J Clin Microbiol. 2006. PMID: 16757611 Free PMC article.
Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor levels.
Colleoni M, Rocca A, Sandri MT, Zorzino L, Masci G, Nolè F, Peruzzotti G, Robertson C, Orlando L, Cinieri S, de BF, Viale G, Goldhirsch A. Colleoni M, et al. Among authors: zorzino l. Ann Oncol. 2002 Jan;13(1):73-80. doi: 10.1093/annonc/mdf013. Ann Oncol. 2002. PMID: 11863115 Free article. Clinical Trial.
Metronomic low-dose oral cyclophosphamide and methotrexate plus or minus thalidomide in metastatic breast cancer: antitumor activity and biological effects.
Colleoni M, Orlando L, Sanna G, Rocca A, Maisonneuve P, Peruzzotti G, Ghisini R, Sandri MT, Zorzino L, Nolè F, Viale G, Goldhirsch A. Colleoni M, et al. Among authors: zorzino l. Ann Oncol. 2006 Feb;17(2):232-8. doi: 10.1093/annonc/mdj066. Epub 2005 Dec 1. Ann Oncol. 2006. PMID: 16322118 Free article. Clinical Trial.
Epidermal growth factor receptor serum (sEGFR) level may predict response in patients with EGFR-positive advanced colorectal cancer treated with gefitinib?
Zampino MG, Magni E, Santoro L, Zorzino L, Dell'Orto P, Sonzogni A, Fazio N, Monfardini L, Chiappa A, Biffi R, de Braud F. Zampino MG, et al. Among authors: zorzino l. Cancer Chemother Pharmacol. 2008 Dec;63(1):139-48. doi: 10.1007/s00280-008-0722-x. Epub 2008 Mar 8. Cancer Chemother Pharmacol. 2008. PMID: 18327586 Clinical Trial.
50 results